AstraZeneca 2Q Rev. $6.45B; Est. $6.33B
July 31 (Bloomberg) –- Bloomberg’s Caroline Hyde reports earnings for AstraZeneca, Britain’s second-biggest drug maker, which raised its full-year forecast. She speaks to Mark Barton and Ryan Chilcote on Bloomberg Television’s “Countdown.” (Source: Bloomberg)
Most Recent Videos
BOJ Policy: How Will the Decision Impact the Yen?
54:14 - Shusuke Yamada, chief Japan FX strategist at Bank of America Merrill Lynch, discusses the Bank of Japan's policy decision, how it will impact the yen and the possibility of helicopter money entering the market. He speaks to Bloomberg's Yvonne Man on "Daybreak Asia." (Source: Bloomberg)